Statement by Research!America President and CEO Mary Woolley on 21st Century Cures Draft Bill

Wednesday, April 29, 2015

We’re thrilled that members of Congress came together on a bipartisan basis to take the next step with this important initiative to accelerate the discovery, development and delivery of lifesaving treatments for patients.  Chairman Fred Upton (R-MI) and Representative Diana DeGette (D-CO) have maintained from the beginning that they would boost funding for medical research, and they followed through with a $10 billion increase for the National Institutes of Health (NIH) over five years in this legislation.  While it is important for the final language in the bill to allow for flexibility in the use of these funds in order to maximize their benefit, these additional dollars can empower NIH to sustain and embark on innovative studies that could reduce the prevalence and impact of costly and disabling conditions that continue to threaten individual and population health, our economic security, and global competitiveness. The Food and Drug Administration (FDA) also requires additional resources to fulfill new responsibilities outlined in the bill. We look forward to reviewing the many other important provisions in this bill and offering input as the committee process moves forward.



Media Contacts

Robert Shalett
Director of Communications 

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco